| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |